FOSapretero Injection
By FOSapretero
Rx
1 Injection in a Vial

Composition
Fosaprepitant(150mg)

Manufacturer - Hetero Drugs Ltd
7-2-A2, Hetero Corporate, Industrial Estates, Sanath Nagar, Hyderabad – 500 018. Telangana, INDIA

Expires on or after
April, 2027

liver
FOSapretero Injection should be used carefully in individuals with severe liver disease. It may be necessary to adjust the dosage of FOSapretero Injection in these patients. It is important to consult a healthcare professional before using this medication. However, no dose adjustment is typically required for individuals with moderate to severe liver disease. If you have any concerns about how your liver condition may affect the use of FOSapretero Injection, it's best to seek advice from your healthcare provider.

kidney
FOSapretero Injection can be used safely in patients with kidney disease. It is not necessary to adjust the dose of FOSapretero Injection for patients with kidney issues.

alcohol
It is unsafe to consume alcohol with FOSapretero Injection.

driving
FOSapretero Injection might reduce alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these effects.

pregnancy
FOSapretero Injection is generally safe to use during pregnancy. Animal studies found minimal harm to the baby, but human studies are limited.

breastfeeding
FOSapretero Injection may not be safe to use during breastfeeding as it may pass into breastmilk and harm the baby. Limited human data is available on this.
| Habit Forming | No |
| Chemical Class | Phenylmorpholine Derivative |
| Therapeutic Class | GASTRO INTESTINAL |
| Action Class | NK1 Antagonists |
₹2375
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024
